# NATCO Pharma Limited Chemical Division Chennai, Chennai, India – FDA Inspections

Source: https://www.keypedia.com/companies/natco-pharma-limited-chemical-division-chennai/c2978c98-d900-4777-9b55-7c62f09edfe0

> Inspection records and compliance data for NATCO Pharma Limited Chemical Division Chennai in Chennai. 3 FDA inspections on record, 1 Form 483, last inspected November 21, 2025.

---

## Details

- Name: NATCO Pharma Limited Chemical Division Chennai
- FEI Number: 3009870595
- Business Operations: API MANUFACTURE
- Address Line 1: 74/7b Vaikkadu Tpp Salai
- City: Chennai
- Country Name: India
- Address: 74/7b Vaikkadu Tpp Salai, Chennai, India
- Country: India

## Related Documents

- [483 - NATCO Pharma Limited Chemical Division Chennai - 2025-11-21](https://www.keypedia.com/records/483/natco-pharma-limited-chemical-division-chennai/ccd7fa17-7d9c-41c1-b8eb-fad2bb3518c9) — source: FDA, date: November 21, 2025
- FDA Inspection 1292172 - NATCO Pharma Limited Chemical Division Chennai - 2025-11-21 — source: FDA, date: November 21, 2025
- [FDA Inspection 1292172 - NATCO Pharma Limited Chemical Division Chennai - 2025-11-21](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited-chemical-division-chennai/8aade8f7-cd63-4bf5-98e2-89992e47d8df) — source: FDA, date: November 21, 2025
- FDA Inspection 1292172 - NATCO Pharma Limited Chemical Division Chennai - 2025-11-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2025
- FDA Inspection 1292172 - NATCO Pharma Limited Chemical Division Chennai - 2025-11-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2025
- [483 - NATCO Pharma Limited Chemical Division Chennai - 2025-06-19](https://www.keypedia.com/records/483/natco-pharma-limited-chemical-division-chennai/2ce2ef17-813a-446e-9898-a324eb76b89a) — source: FDA, date: June 19, 2025
- FDA Inspection 1103024 - NATCO Pharma Limited Chemical Division Chennai - 2019-07-12 — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2019
- FDA Inspection 958408 - NATCO Pharma Limited Chemical Division Chennai - 2016-02-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2016

## Related Companies

- [Andhra Organics Limited](https://www.keypedia.com/companies/andhra-organics-limited/57dd3443-47f0-4e8d-9940-c4f7e9c61e08)
- [Vamsi Labs Ltd](https://www.keypedia.com/companies/vamsi-labs-ltd/6beaf68e-e00d-4385-ac91-70edabcfce9b)
- [Veranova LP](https://www.keypedia.com/companies/veranova-lp/22f7ea09-da55-4ee1-aa40-fce66fa3ef61)
- [Zhejiang Hisun Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-hisun-pharmaceutical-co-ltd/38a26f64-d8df-4781-8322-3606f62da25d)
- [Fukuzyu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de)
- [VUAB Pharma a.s.](https://www.keypedia.com/companies/vuab-pharma-as/6caae203-57d0-4a6f-b2b8-340c40ec5135)
- [Hikal Limited](https://www.keypedia.com/companies/hikal-limited/cb3e9445-04eb-4d52-af78-793b43f9d61f)
- [Symbiotec Pharmalab Limited](https://www.keypedia.com/companies/symbiotec-pharmalab-limited/70a966a5-ef02-46b0-8e2a-8a953f473496)
- [Sionc Pharmaceuticals Private Limited, Unit II](https://www.keypedia.com/companies/sionc-pharmaceuticals-private-limited-unit-ii/b8c15cec-62ee-46e2-9e6d-afd955c22a5c)
- [Hubei Honch Pharmaceutical Co, Ltd.](https://www.keypedia.com/companies/hubei-honch-pharmaceutical-co-ltd/312d98b2-421d-409e-9e00-39283154c293)

## Related Officers

- [Sen Lin](https://www.keypedia.com/people/sen-lin/3ab3159c-49a6-4258-8de7-2c4d14d6429f)
- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)
- [investigator](https://www.keypedia.com/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)
- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
